AU3733100A - Compounds that disrupt mammalian rad51 activity - Google Patents

Compounds that disrupt mammalian rad51 activity

Info

Publication number
AU3733100A
AU3733100A AU37331/00A AU3733100A AU3733100A AU 3733100 A AU3733100 A AU 3733100A AU 37331/00 A AU37331/00 A AU 37331/00A AU 3733100 A AU3733100 A AU 3733100A AU 3733100 A AU3733100 A AU 3733100A
Authority
AU
Australia
Prior art keywords
compounds
rad51 activity
mammalian rad51
disrupt
disrupt mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37331/00A
Inventor
Xiaohai Gong
Paul Hasty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lexicon Pharmaceuticals Inc
Original Assignee
Lexicon Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Genetics Inc filed Critical Lexicon Genetics Inc
Publication of AU3733100A publication Critical patent/AU3733100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU37331/00A 1999-03-09 2000-03-09 Compounds that disrupt mammalian rad51 activity Abandoned AU3733100A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12343899P 1999-03-09 1999-03-09
US60123438 1999-03-09
US12821499P 1999-04-07 1999-04-07
US60128214 1999-04-07
PCT/US2000/006125 WO2000053630A2 (en) 1999-03-09 2000-03-09 COMPOUNDS THAT DISRUPT MAMMALIAN Rad51 ACTIVITY

Publications (1)

Publication Number Publication Date
AU3733100A true AU3733100A (en) 2000-09-28

Family

ID=26821557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37331/00A Abandoned AU3733100A (en) 1999-03-09 2000-03-09 Compounds that disrupt mammalian rad51 activity

Country Status (2)

Country Link
AU (1) AU3733100A (en)
WO (1) WO2000053630A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2909383C (en) 2012-04-12 2020-11-10 University Of Saskatchewan Phthalocyanine compounds useful as reca inhibitors and methods of using same
CN116217657A (en) 2016-05-27 2023-06-06 辛赛克斯公司 Protein interface
GB2584210B (en) 2017-11-22 2022-03-16 Synthex Inc Peptides for inhibiting RAD51

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037125A (en) * 1996-11-05 2000-03-14 Lexicon Genetics Incorporated Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells

Also Published As

Publication number Publication date
WO2000053630A3 (en) 2001-05-31
WO2000053630A2 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
AU5546000A (en) Compounds
AUPP873799A0 (en) Pyridine compounds
AU1995800A (en) Particle manipulation
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU2678800A (en) Modified calycins
AU1132601A (en) Feature interactions
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AUPQ262599A0 (en) Gene expression
AU3178200A (en) Genetic analysis
AU7318700A (en) Novel transaldolase gene
AU6642900A (en) Improved materials for mycoculture
AU3733100A (en) Compounds that disrupt mammalian rad51 activity
AU4974800A (en) Eosinophil degranulating conditions
AU2207001A (en) Novel compounds and process
AU6006800A (en) Treating cells
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
AU4755200A (en) Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives
AU7279000A (en) Panel-shaped loudspeaker
AU4861300A (en) Oven
AU7617200A (en) Chemical feeder
AU6382000A (en) Genome analysis
AU4959100A (en) Container/surround assemblies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase